601607 Shanghai Pharmaceuticals Holding
- 19.25
- +0.54+2.89%
Shanghai Pharmaceuticals Holding News
Sh Pharma's Prompt Announcement Regarding the Third Exercise Period of the First Grant of Stock Options under the 2019 A-share Stock Option Incentive Plan and Restrictions on the Second Exercise Period of Reserved Stock Options
Announcement from sh pharma on the approval of production of ibuprofen tablets.
Announcement of Approval of Production of Sitagliptin Phosphate Tablets by Shanghai Pharmaceuticals Group Co., Ltd.
Announcement from sh pharma regarding the clinical trial approval notice for WST03 preparation.
Announcement on the results of the third exercise period of the 2019 A-share stock option incentive plan and the second reserved exercise period of stock options for the second quarter of 2024 granted for the first time by Shanghai Pharmaceuticals Group Co., Ltd.
Announcement of the Resolution of the Twelfth Meeting of the Eighth Board of Directors of sh pharma Group Co., Ltd.
Legal Opinion of Guohao Law Firm (Shanghai) on the Shanghai Pharma Group Co., Ltd.'s 2023 Annual Shareholders' Meeting.
Announcement of the 2023 Annual Shareholders' Meeting Resolutions of SH Pharma Group Co., Ltd.
Announcement of sh pharma's approval of the listing application for hydrocortisone active pharmaceutical ingredient.
Announcement: Approval of the market application of the active pharmaceutical ingredient sodium warfarin by SH Pharma Group Co., Ltd.
Notice on Convening the 2023 Annual Shareholders' Meeting of sh pharma Group Co., Ltd.
Announcement on the Progress of Pharmaceutical Clinical Trials by SH Pharma Group Co., Ltd.
Announcement Regarding the Consistent Evaluation of Dapantinib Tablets for Generic Drugs by SH Pharma Group Co., Ltd.
Notice of Shanghai Pharma Holding Co., Ltd. on Convening the Annual Shareholders' Meeting in 2023.
Meeting documents for the 2023 Annual Shareholders' Meeting of Sh Pharma Group Co., Ltd.
Announcement of the resolution of the seventh meeting of the eighth session of the board of supervisors of SH Pharma Group Co., Ltd.
Announcement of Shanghai Pharma Group Co., Ltd. regarding the mid-term dividend arrangement for 2024.
Announcement of Resolutions of the 10th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
202405 Shanghai Pharmaceutical Investor Relations Activity Record Form - v2
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of maxitengtan tablets
Analysis
Price Target
No Data
